Cancer Research Cancer Epigenetics  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pati, D.
Right arrow Articles by Medina, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pati, D.
Right arrow Articles by Medina, D.
[Cancer Research 64, 5608-5616, August 15, 2004]
© 2004 American Association for Cancer Research


Regular Articles

Hormone-Induced Chromosomal Instability in p53-Null Mammary Epithelium

Debananda Pati1, Bassem R. Haddad3, Albert Haegele6, Henry Thompson6, Frances S. Kittrell2, Anne Shepard2, Cristina Montagna4, Nenggang Zhang1, Gouqing Ge1, Subhendu Kumar Otta1, Maureen McCarthy5, Robert L. Ullrich7 and Daniel Medina2

Departments of 1 Pediatrics, Hematology-Oncology, Texas Children’s Cancer Center, and 2 Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas; 3 Lombardi Cancer Center and Institute for Molecular Human Genetics, Georgetown University Medical Center, Washington, District of Columbia; 4 Genetics Branch, Center for Cancer Research, NIH, Bethesda, Maryland; 5 Department of Microbiology, University of Texas Medical Branch, Galveston, Texas; 6 Division of Laboratory Research, AMC Cancer Research Center, Denver; 7 Department of Radiological Health Sciences, Colorado State University, Fort Collins, Colorado

The absence of p53 function increases risk for spontaneous tumorigenesis in the mammary gland. Hormonal stimulation enhances tumor risk in p53-null mammary epithelial cells as well as the incidence of aneuploidy. Aneuploidy appears in normal p53-null mammary epithelial cells within 5 weeks of hormone stimulation. Experiments reported herein assessed a possible mechanism of hormone-induced aneuploidy. Hormones increased DNA synthesis equally between wild-type (WT) and p53-null mammary epithelial cells. There were two distinct responses in p53-null cells to hormone exposure. First, Western blot analysis demonstrated that the levels of two proteins involved in regulating sister chromatid separation and the spindle checkpoint, Mad2 and separase (ESPL1) were increased in null compared with WT cells. In contrast, the levels of securin and Rad21 proteins were not increased in hormone-stimulated p53-null compared with WT cells. ESPL1 RNA was also increased in p53-null mouse mammary cells in vivo by 18 h of hormone stimulation and in human breast MCF7 cells in monolayer culture by 8 h of hormone stimulation. Furthermore, both promoters contained p53 and steroid hormone response elements. Mad2 protein was increased as a consequence of the absence of p53 function. The increase in Mad2 protein was observed also at the cellular level by immunohistochemistry. Second, hormones increased gene amplication in the distal arm of chromosome 2, as shown by comparative genomic hybridization. These results support the hypothesis that hormone stimulation acts to increase aneuploidy by several mechanisms. First, by increasing mitogenesis in the absence of the p53 checkpoint in G2, hormones allow the accumulation of cells that have experienced chromosome missegregation. Second, the absolute rate of chromosome missegregation may be increased by alterations in the levels of two proteins, separase and Mad2, which are important for maintaining chromosomal segregation and the normal spindle checkpoint during mitosis.




This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
T. M. Horton, G. Jenkins, D. Pati, L. Zhang, M. E. Dolan, A. Ribes-Zamora, A. A. Bertuch, S. M. Blaney, S. L. Delaney, M. Hegde, et al.
Poly(ADP-ribose) polymerase inhibitor ABT-888 potentiates the cytotoxic activity of temozolomide in leukemia cells: influence of mismatch repair status and O6-methylguanine-DNA methyltransferase activity
Mol. Cancer Ther., August 1, 2009; 8(8): 2232 - 2242.
[Abstract] [Full Text] [PDF]


Home page
Am J Clin PatholHome page
L. Wang, F. Yin, Y. Du, W. Du, B. Chen, Y. Zhang, K. Wu, J. Ding, J. Liu, and D. Fan
MAD2 as a Key Component of Mitotic Checkpoint: A Probable Prognostic Factor for Gastric Cancer
Am J Clin Pathol, June 1, 2009; 131(6): 793 - 801.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. Meyer, V. Fofanov, AnilK. Panigrahi, F. Merchant, N. Zhang, and D. Pati
Overexpression and Mislocalization of the Chromosomal Segregation Protein Separase in Multiple Human Cancers
Clin. Cancer Res., April 15, 2009; 15(8): 2703 - 2710.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. Zhang, G. Ge, R. Meyer, S. Sethi, D. Basu, S. Pradhan, Y.-J. Zhao, X.-N. Li, W.-W. Cai, A. K. El-Naggar, et al.
Overexpression of Separase induces aneuploidy and mammary tumorigenesis
PNAS, September 2, 2008; 105(35): 13033 - 13038.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
E Burum-Auensen, P M DeAngelis, A R Schjolberg, J. Roislien, S N Andersen, and O P F Clausen
Spindle proteins Aurora A and BUB1B, but not Mad2, are aberrantly expressed in dysplastic mucosa of patients with longstanding ulcerative colitis
J. Clin. Pathol., December 1, 2007; 60(12): 1403 - 1408.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
E. Burum-Auensen, P. M. De Angelis, A. R. Schjolberg, K. L. Kravik, M. Aure, and O. P. F. Clausen
Subcellular Localization of the Spindle Proteins Aurora A, Mad2, and BUBR1 Assessed by Immunohistochemistry
J. Histochem. Cytochem., May 1, 2007; 55(5): 477 - 486.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
Y.-L. Lo, J.-C. Yu, S.-T. Chen, G.-C. Hsu, Y.-C. Mau, S.-L. Yang, P.-E. Wu, and C.-Y. Shen
Breast cancer risk associated with genotypic polymorphism of the mitotic checkpoint genes: a multigenic study on cancer susceptibility
Carcinogenesis, May 1, 2007; 28(5): 1079 - 1086.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
D. Medina
Mammary developmental fate and breast cancer risk
Endocr. Relat. Cancer, September 1, 2005; 12(3): 483 - 495.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.